, ,
This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
Item | Value |
---|---|
Country | United States |
Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Facebook username | gatesfoundation |
LinkedIn username | bill-&-melinda-gates-foundation |
Website | https://www.gatesfoundation.org/ |
Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
Twitter username | gatesfoundation |
Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
Regularity with which donor updates donations data | continuous updates |
Regularity with which Donations List Website updates donations data (after donor update) | irregular |
Lag with which donor updates donations data | months |
Lag with which Donations List Website updates donations data (after donor update) | years |
Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda Gates Foundation
Item | Value |
---|---|
Country | |
Facebook page | OHSUedu |
Website | http://www.ohsu.edu/xd |
Twitter username | OHSUNews |
Wikipedia page | https://en.wikipedia.org/wiki/Oregon_Health_%26_Science_University |
Full donee page for donee Oregon Health & Science University
Item | Value |
---|
Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | 25 | 999,998 | 2,788,994 | -22,676 | 100,000 | 100,000 | 295,046 | 419,895 | 999,998 | 1,303,692 | 2,956,358 | 3,946,778 | 4,999,999 | 25,020,336 |
Global health | 18 | 1,000,000 | 3,333,959 | -22,676 | 100,000 | 100,000 | 398,238 | 999,998 | 1,000,000 | 2,871,805 | 2,956,358 | 4,832,375 | 7,958,944 | 25,020,336 |
Family planning | 4 | 295,046 | 1,501,204 | 100,000 | 100,000 | 100,000 | 295,046 | 295,046 | 295,046 | 609,772 | 609,772 | 4,999,999 | 4,999,999 | 4,999,999 |
Nutrition | 3 | 599,999 | 1,236,260 | 110,000 | 110,000 | 110,000 | 110,000 | 599,999 | 599,999 | 599,999 | 2,998,782 | 2,998,782 | 2,998,782 | 2,998,782 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global health (filter this donor) | 18 | 60,011,256.98 | 5,032,199.00 | 398,238.00 | 8,114,560.98 | 2,956,358.00 | 30,479,154.00 | 2,871,805.00 | 1,999,998.00 | 7,958,944.00 | 0.00 | 100,000.00 | 100,000.00 |
Family planning (filter this donor) | 4 | 6,004,817.35 | 0.00 | 609,772.35 | 0.00 | 0.00 | 4,999,999.00 | 295,046.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | 0.00 |
Nutrition (filter this donor) | 3 | 3,708,781.00 | 0.00 | 0.00 | 599,999.00 | 0.00 | 2,998,782.00 | 0.00 | 0.00 | 110,000.00 | 0.00 | 0.00 | 0.00 |
Total | 25 | 69,724,855.33 | 5,032,199.00 | 1,008,010.35 | 8,714,559.98 | 2,956,358.00 | 38,477,935.00 | 3,166,851.00 | 1,999,998.00 | 8,068,944.00 | 100,000.00 | 100,000.00 | 100,000.00 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
Amount (current USD) | Amount rank (out of 25) | Donation date | Cause area | URL | Influencer | Notes |
---|---|---|---|---|---|---|
4,832,375.00 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide fundamental research on a new type of vaccine-elicited CD8+ T cell immunity with the potential to control and clear HIV, and therefore to enable development of a safe and effective HIV/AIDS vaccine for use in high burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
199,824.00 | 19 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to explore the potential for MAIT cell targeted vaccination to prevent TB. Targeting MAIT cells for TB vaccines. Investment start date: 10/26/2015 to end date: 4/30/2019. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
398,238.00 | 17 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to explore the ability of anti-Mycobacterium tuberculosis nanobodies to penetrate granulomas; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
609,772.35 | 14 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop a new class of novel, orally active non-hormonal candidates and perform initial pre-clinical evaluations to provide preliminary data for the approach as an on-demand contraceptive method for women; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,886,767.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to determine if vaccination can reduce Campylobacter infection and environmental enteric dysfunction (EED), thereby improving gut health while increasing infant growth trajectories; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-22,676.02 | 25 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | To hold an international summit in May 2015 for nutrition scientists and developing country program implementers, to encourage dialogue and collaboration for the purpose of improving preconception and maternal nutritional status among adolescent girls and; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,303,692.00 | 11 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support pre-clinical and early clinical development of a novel TB vaccine for use in high burden countries in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
3,946,778.00 | 6 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the testing of the prototype(s) live attenuated CMV based HIV vaccine in first in human experimental medicine trial; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
599,999.00 | 15 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to develop and characterize a non-human primate (NHP) model of environmental enteric dysfunction (EED) that can be used to down-select and de-risk potential preventative and therapeutic interventions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,956,358.00 | 8 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to explore the potential for MAIT cell targeted vaccination to prevent TB. Targeting MAIT cells for TB vaccines. Investment start date: 10/26/2015 to end date: 4/30/2019. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
4,999,999.00 | 3 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop additional safe, effective, acceptable and accessible methods of permanent or very long-acting contraception that will fill an unmet need for women who have reached their desired family size and do not wish to become pregnant again; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to identify pre- and early post-natal biomarkers that can predict the later aberrant development of certain cognitive functions important for many social and academic skills, to enable early treatment; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
4,938,923.00 | 4 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide fundamental research on a new type of vaccine-elicited CD8+ T cell immunity with the potential to control and clear HIV, and therefore to enable development of a safe and effective HIV/AIDS vaccine for use in high burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,998,782.00 | 7 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | To better understand the mechanisms linking maternal nutrition and child health, we propose to establish a multidisciplinary team of experts to develop a new highly relevant and translational nonhuman primate (NHP) model in which to systematically dissect; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
25,020,336.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the testing of the prototype(s) live attenuated CMV based HIV vaccine in first in human experimental medicine trial; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
419,895.00 | 16 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | To hold an international summit in May 2015 for nutrition scientists and developing country program implementers, to encourage dialogue and collaboration for the purpose of improving preconception and maternal nutritional status among adolescent girls and; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
2,871,805.00 | 10 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support CMV vector-based Vaccine Concept. CMV vector-based Vaccine Concept. Investment start date: 10/8/2013 to end date: 4/30/2016. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
295,046.00 | 18 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support preparation leading to the development of a plan for a research center of excellence devoted to the development of a voluntary low-cost, highly acceptable, and easily administered non-surgical method of permanent female contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,000,000.00 | 12 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to further test the feasibility of using the varicose vein treatment polidocanol in a foam format as a potential method of permanent contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
999,998.00 | 13 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to target T-cells against ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
7,958,944.00 | 2 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop a safe and effective CMV/HIV vaccine that will fully exploit the early vulnerability of HIV infection to potent effector-memory T cell responses, and will be suitable for clinical translation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
110,000.00 | 20 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | for conference support. DOHAD Conference Grant. Investment start date: 6/24/2011 to end date: 12/31/2011. Grantee name: Oregon Health and Science University Foundation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to test the feasibility of using the varicose vein treatment polidocanol to permanently close fallopian tubes, offering a low-cost, nonsurgical sterilization method for administration by minimally trained healthcare workers in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to target T-cells against these ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to work to design components of an HIV vaccine using groups of related envelope sequences.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |